
|Articles|December 15, 2021
Daily Medication Pearl: Ondansetron Hydrochloride (Zofran)
Author(s)Saro Arakelians, PharmD
Zofran aids in the prevention of nausea and vomiting.
Advertisement
Medication Pearl of the Day: Ondansetron Hydrochloride (Zofran)
Indication: Zofran is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting.
Insight:
- Dosing: Take 1 tablet every day or as needed prescribed by the provider.
- Dosage forms: Tablets 4 mg and 8 mg (orally disintegrating tablets available), oral solution 4 mg/5 mL.
- Adverse events (AEs): The most common AEs in adults are headache, malaise/fatigue, constipation, and diarrhea.
- Mechanism of action: Ondansetron is a selective 5-HT3 receptor antagonist.
- Manufacturer: GSK
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Current Pneumococcal Vaccination Recommendations: A Clinical Update
2
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
3
New 2025 Hypertension Management Guidelines Include Key Updates
4
Preparing for the RNA Therapy Pipeline in Lipid Management
5

























